Time on boards
- Boards served
- 5
- Current seats
- 5
- Board service
- 3 years
- Director since
- 2025
3 years of board service in total across 5 boards, counting each seat separately. Longest: BlackRock Health Sciences Term Trust, 10 months.
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 27, 2026 | BlackRock Capital Allocation Term Trust | In-the-money exercise | +1,840 | — | — |
| Feb 27, 2026 | Blackrock MuniYield New York Quality Fund Inc.Common Stock | Open-market purchase | +49,025 | $10.15 | $497,604 |
| Dec 19, 2025 | BlackRock Health Sciences Term Trust | Open-market sale | −0 | $14.96 | $6 |
| Dec 19, 2025 | BlackRock Technology and Private Equity Term Trust | Open-market sale | −1 | $6.55 | $5 |
| Dec 19, 2025 | BlackRock Science and Technology Term Trust | Open-market sale | −1 | $22.73 | $15 |
| Dec 19, 2025 | BlackRock Health Sciences Term Trust | Open-market sale | −0 | $14.96 | $6 |
| Dec 18, 2025 | BlackRock Health Sciences Term Trust | Open-market sale | −10,294 | $14.98 | $154,204 |
| Dec 18, 2025 | BlackRock Technology and Private Equity Term Trust | Open-market sale | −21,936 | $6.52 | $143,023 |
| Dec 18, 2025 | BlackRock Science and Technology Term Trust | Open-market sale | −9,293 | $22.51 | $209,185 |
| Dec 18, 2025 | BlackRock Health Sciences Term Trust | Open-market sale | −10,294 | $14.98 | $154,204 |
Questions about Robert W. Fairbairn
What boards is Robert W. Fairbairn on?
Robert W. Fairbairn sits on the boards of BlackRock Capital Allocation Term Trust, BlackRock Health Sciences Term Trust, BlackRock Science and Technology Term Trust, BlackRock Technology and Private Equity Term Trust and Blackrock MuniYield New York Quality Fund Inc.Common Stock.
How long has Robert W. Fairbairn served on boards?
Our records show at least 3 years of board service across 5 boards, the earliest from 2025.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.